Teva Pharmaceutical Industries (TEVA) Deferred Taxes (2009 - 2026)
Teva Pharmaceutical Industries' (TEVA) quarterly Deferred Taxes came in at $25.0 million in Q2 2026, up 111.85% YoY from $11.8 million in Q2 2025, and up 213.64% on a QoQ basis from -$22.0 million in Q1 2026.
Teva Pharmaceutical Industries (TEVA) Deferred Taxes (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 18 years of Deferred Taxes data on file, last reported at $25.0 million in Q2 2026.
- Quarterly Deferred Taxes rose 111.85% year-over-year to $25.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$485.0 million (down 137.75% YoY) and the FY2025 annual result came in at -$671.0 million, down 5.84% from the prior year.
- Deferred Taxes rose to $25.0 million in Q2 2026, from -$22.0 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $150.0 million in Q4 2022 to a low of -$1.1 billion in Q2 2022.
- A 5-year average of -$149.1 million and a median of -$48.5 million in 2023 frame the typical range for Deferred Taxes.
- The widest YoY moves for Deferred Taxes: up 450.0% in 2022, down 6868.75% in 2022.
- Tracing TEVA's Deferred Taxes over 5 years: stood at $150.0 million in 2022, then tumbled by 78.67% to $32.0 million in 2023, then changed by 0.0% to $32.0 million in 2024, then sank by 1959.38% to -$595.0 million in 2025, then surged by 104.2% to $25.0 million in 2026.
- The last three Deferred Taxes figures came in at $25.0 million (Q2 2026), -$22.0 million (Q1 2026), and -$595.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | 9.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.00 Mn |
| Mar 31, 2026 | -22.00 Mn |
| Dec 31, 2025 | -595.00 Mn |
| Sep 30, 2025 | 107.00 Mn |
| Jun 30, 2025 | -211.00 Mn |
| Mar 31, 2025 | 28.00 Mn |
| Dec 31, 2024 | 32.00 Mn |
| Sep 30, 2024 | -53.00 Mn |
| Jun 30, 2024 | -424.00 Mn |
| Mar 31, 2024 | -189.00 Mn |
| Dec 31, 2023 | 32.00 Mn |
| Sep 30, 2023 | -199.00 Mn |
| Jun 30, 2023 | -44.00 Mn |
| Mar 31, 2023 | -106.00 Mn |
| Dec 31, 2022 | 150.00 Mn |
| Sep 30, 2022 | 44.00 Mn |
| Jun 30, 2022 | -1.08 Bn |
| Mar 31, 2022 | -175.00 Mn |
| Dec 31, 2021 | -133.00 Mn |
| Sep 30, 2021 | 8.00 Mn |